477 related articles for article (PubMed ID: 34713300)
1. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S‑transferase ω 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non‑small cell lung cancer cells, via the JAK/STAT3 signaling pathway.
Wang K; Zhang FL; Jia W
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236161
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.
Liu S; Ge X; Su L; Zhang A; Mou X
Mol Med Rep; 2018 Mar; 17(3):3979-3986. PubMed ID: 29286124
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung carcinoma via miR‑1183 and PI3K/PKB pathway.
Wu W; Xi W; Li H; Yang M; Yao X
Int J Mol Med; 2020 Jun; 45(6):1814-1824. PubMed ID: 32236577
[TBL] [Abstract][Full Text] [Related]
5. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
Tang Q; Li M; Chen L; Bi F; Xia H
Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
[TBL] [Abstract][Full Text] [Related]
6. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer.
Li K; Yuan C
Int J Mol Med; 2020 Sep; 46(3):1013-1028. PubMed ID: 32582959
[TBL] [Abstract][Full Text] [Related]
9. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma.
Zhou S; Xu J; Zhu Y
Arch Biochem Biophys; 2024 Jun; 756():110002. PubMed ID: 38636689
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
Li WQ; Zhang JP; Wang YY; Li XZ; Sun L
Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
[TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway.
Zhao L; Song X; Guo Y; Ding N; Wang T; Huang L
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34132359
[TBL] [Abstract][Full Text] [Related]
13. EPN3 plays oncogenic role in non-small cell lung cancer by activating the JAK1/2-STAT3 pathway.
Meng J; Zhang C; Zhu N; Zhang C; Liu M; Han Z; Li Y
Environ Toxicol; 2023 Aug; 38(8):1968-1979. PubMed ID: 37186036
[TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.
Chen G; Zheng Z; Li J; Zhang P; Wang Z; Guo S; Ma J; Shen J; Li H
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495838
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid re‑sensitises gefitinib‑resistant lung cancer cells by inhibiting the JAK/STAT3 signalling pathway and reversing epithelial‑mesenchymal transition.
Yang X; Gao Y; Liu Q; Wan L; Liu H; Bian W; Du Y; Huang C
Oncol Rep; 2021 Feb; 45(2):459-468. PubMed ID: 33416163
[TBL] [Abstract][Full Text] [Related]
16. Silencing of immunoglobulin superfamily containing leucine-rich repeat inhibits gastric cancer cell growth and metastasis by regulating epithelial-mesenchymal transition.
Sun A; Li J; Kong W; Jiang X
Bioengineered; 2022 May; 13(5):13544-13554. PubMed ID: 35653801
[TBL] [Abstract][Full Text] [Related]
17. NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a.
Chen Z; Che Q; Xie C
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300080
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
Fan H; Li J; Wang J; Hu Z
Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
[TBL] [Abstract][Full Text] [Related]
20. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
[Next] [New Search]